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Abstract Prions are proteinsmost commonly associatedwith fatal neurodegenerative
diseases in mammals but are also responsible for a number of harmless heritable phe-
notypes in yeast. These states arise when a misfolded form of a protein appears and,
rather than be removed by cellular quality controlmechanisms, persists. Themisfolded
prion protein forms aggregates and is capable of converting normally folded protein
to the misfolded state through direct interaction between the two forms. The dominant
mathematical model for prion aggregate dynamics has been the nucleated polymeriza-
tion model (NPM) which considers the dynamics of only the normal protein and the
aggregates. However, for yeast prions the molecular chaperone Hsp104 is essential for
prion propagation. Further, although mammals do not express Hsp104, experimental
assays have shown Hsp104 also interacts with mammalian prion aggregates. In this
study, we generalize the NPM to account for molecular chaperones and develop what
we call the enzyme-limited nucleated polymerization model (ELNPM). We discuss
existence, uniqueness and stability of solutions to our model and demonstrate that the
NPM represents a quasi-steady-state reduction of our model. We validate the ELNPM
by demonstrating agreement with experimental results on the yeast prion [PSI+] that
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could not be supported by the NPM. Finally, we demonstrate that, in contrast to the
NPM, the ELNPM permits the coexistence of multiple prion strains.
Keywords Nucleated polymerization · Prions · Protein aggregation · Protein
misfolding · Yeast
Mathematics Subject Classification 92B05 · 92C45
1 Introduction
The central dogma of molecular biology stipulates that phenotypes, an organism’s
expressed states, are determined by genotypes, the vertically transmitted DNA (Crick
1958). However, the link between genotype and phenotype is not always this direct.
Todaywe understand that a number of phenotypes are determined epigenetically, with-
out a change to the nucleotide sequence of DNA (Goldberg et al. 2007). In 1965, a
number of yeast phenotypes were found to violate the laws of Mendelian inheritance
and were thus inconsistent with DNA-based transmission (Cox et al. 1988). Further
experimental studies demonstrated that the phenotypic states were not the function of
the underlying DNA but were the function of a misfolded (prion) protein (Wickner
1994). As such, the phenotypes were transmitted by the proteins themselves. This
phenomenon of “protein only inheritance,” also called the prion hypothesis, has over
time gone from highly controversial to commonly accepted (Tuite and Serio 2010).
Today, nearly a dozen proteins in yeast have been shown to be able to behave as prions
(Liebman andChernoff 2012). Of course, prions extend far beyond yeast. Inmammals,
prions are associated with a number of irreversible fatal neurological diseases such
as Creutzfeldt–Jakob disease, fatal familial insomnia, chronic wasting disease and
bovine spongiform encephalopathy. Mammalian prion diseases have varying modes
of transmission and have been shown to be able to pass from one species to another. At
present, all mammalian prion diseases are the result of a single protein, PrP (Aguzzi
and Polymenidou 2004). In addition, prion diseases are closely related to other pro-
tein misfolding diseases such as Parkinson’s, Huntington’s, Alzheimer’s and diseases
(Brundin et al. 2010; Knowles et al. 2014; Brettschneider et al. 2015).
Although humans are vastly different from yeast, the dynamics of prion proteins in
both hosts is quite similar. Bothmammals and yeast have cellular machinery dedicated
to identifying and removing misfolded proteins (Nelson et al. 2008)—prion proteins
are capable of evading such protective mechanisms and transmitting their misfolded
(prion) state to other normally folded proteins. Prion proteins aggregate into complexes
which act as templates for initiating further misfolding of normally folded protein.
These aggregated complexes may also fragment into smaller units, each of which can
template further misfolding (Sindi and Serio 2009; Tuite and Serio 2010). Finally, in
order to spread the prion state to a colony or throughout a tissue, prion aggregates must
be transmitted to other cells. In yeast colonies, prion aggregates are transmitted from
mother to daughter cells during cell division (Tuite and Cox 2003; Derdowski et al.
2010). In mammalian prion diseases, PrP aggregates are thought to be transmitted
extracellularly (Collinge 2001). For other mammalian neurodegenerative diseases,
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there is a growing body of evidence suggesting neuron to neuron propagation of the
misfolded proteins (Brettschneider et al. 2015).
Many mathematical models have been developed to study the dynamics of prion
aggregates primarily in the context of the mammalian host (Masel et al. 1999; Prüss
et al. 2006; Greer et al. 2006; Calvez et al. 2010). Tanaka et al. (2006) applied these
mathematical models to the [PSI+] prion in yeast. However, experimental studies of
[PSI+] have shown that the molecular chaperone Hsp104 is essential for fragmenta-
tion, and recent studies have demonstrated that Hsp104 acts in a rate limiting fashion
with respect to fragmentation (Satpute-Krishnan et al. 2007; Derdowski et al. 2010).
We also note that fragmentation is important not only for efficient conversion of nor-
mal protein by providingmore templates, but also to ensure there are sufficiently many
templates to allow efficient transmission; thus an accurate model of fragmentation is
essential to understanding the in vivo dynamics of prion aggregates. As such, to accu-
rately model prion aggregates in yeast, the dynamics of Hsp104 and its interaction
with prion aggregates must be considered.
Further, modeling Hsp104 will lend insight to more general prion and protein mis-
folding disorders. Although no chaperones are known to be involved in mammalian
prion dynamics, prion amplification in mammals necessarily requires aggregate frag-
mentation (Masel et al. 1999). In addition, while mammals do not express Hsp104,
recent in vitro work demonstrates that engineered mutants of Hsp104 suppress the
toxicity of misfolded protein aggregates associated with mammalian neurodegenera-
tive disorders (Jackrel and Shorter 2014). At present, no mathematical model exists
which considers the dynamics of protein aggregates in the presence of a chaperone
mediating fragmentation.
In this study we develop a mathematical model of prion dynamics where frag-
mentation requires the interaction of Hsp104 with aggregated proteins. In Sects. 2
and 3 we provide the mathematical background and analysis of our model, which
we call the enzyme-limited nucleated polymerization model (ELNPM). In Sect. 4 we
illustrate the necessity of including enzyme-limited fragmentation by demonstrating
important experimental properties of [PSI+] that are not described by previously pub-
lished mathematical models. We also demonstrate that in contrast to models which
consider only the prion aggregates, interactions with the enzymeHsp104 permit stable
co-existence ofmultiple prion strains. In Sect. 5we provide a summary and concluding
remarks.
2 Mathematical models of prion aggregate fragmentation
We develop our model of enzyme-mediated fragmentation by considering the key bio-
chemical processes involved in the dynamics of prions. We first discuss the dynamics
included in previous mathematical formulations and then detail the additional features
necessary to depict interactions between enzymes and aggregates. Finally, we demon-
strate that through a series of assumptions, consistent with the yeast prion [PSI+], our
system of infinite ordinary differential equations can be analyzed with a 5-dimensional
system of differential equations which approximates the full system dynamics.
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2.1 Prion aggregate dynamics
While the biochemical processes depicted differs between prion model formulations
(Masel et al. 1999; Prüss et al. 2006; Greer et al. 2006; Calvez et al. 2010), in all
cases aggregates change size through conversion and fragmentation. That is, a prion
aggregate increases in length by actively converting and incorporatingnormal (healthy)
protein monomers. Typically, aggregates are assumed to be linear fibrils and, as such,
conversion of normal protein can only take place on one of the fibril ends. Aggregates
may also fragment into two smaller aggregates, each of which now act as a template
to convert additional protein. It is often assumed that any aggregates smaller than the
minimum stable size, n0, immediately disassociate into healthy prion monomers (see
Fig. 1).
Such models are referred to as nucleated polymerization models (NPM); mathe-
matical formulations of the NPM were first introduced and subsequently validated
by Nowak et al. (1998) and Masel et al. (1999). This model is so-named due to the
assumption that there is a minimum “stable” size of a prion aggregate (a nucleus).
The spontaneous formation of such an initial nucleus (or seed, as it is also called)
is the time-limiting step in prion disease initialization, but once seeded, the disease
progresses primarily by the processes of conversion, fragmentation and transmission.
The NPM equations are derived from the Law of Mass Action applied to a minimal
set of kinetic rate equations. Masel et al. (1999) give them as
s′ = αs − μss(t) − 2βs(t)
∞∑
i=n0
ui (t) + γ (n0 − 1)n0
∞∑
i=n0
ui (t), (1)
u′m = −2βs(t)[um(t) − um−1(t)] − [μ0 + γ (m − 1)]um(t) + 2γ
∞∑
i=m+1
ui (t), (2)
where s(t) denotes the concentration of healthy protein and um(t) the density of
aggregates of size m. Many authors (Greer et al. 2006; Prüss et al. 2006; Engler
et al. 2006) have studied the more analytically-tractable equations that come from a
continuous relaxation of aggregate sizes:
s′ = αs − μss(t) − 2βs(t)
∫ ∞
x0
u(t, x)dx + γ x02
∫ ∞
x0
u(t, x)dx, (3)
Fig. 1 Nucleated polymerization model: conversion and fragmentation (n0 = 2). Conversion of healthy
protein (circles) lengthens the aggregate (squares), which may in turn fragment. If a daughter fragment is
smaller than the stable nucleus size (n0), it is immediately disassociated into healthy protein monomers
123
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∂u
∂t
= −2βs(t)∂u
∂x
− [μ0 + γ x]u(t, x) + 2γ
∫ ∞
x
u(t, y) dy. (4)
Though it is known that this latter system converges weakly to the former in the limit
of large average aggregate size under very general assumptions (Doumic et al. 2009;
Doumic and Gabriel 2010), we choose to generalize the discrete model for simplicity.
In adapting this prion model to yeast, we identify the kinetic parameters as repre-
senting the following physical quantities:
• αs the basal rate of transcription of Sup35,
• μs the decay (or dilution) rate of Sup35,
• n0 the minimum stable aggregate size (aggregates of size smaller than n0 imme-
diately disassociate into soluble Sup35),
• μ0 the decay (or dilution) rate of aggregated protein,
• β the rate of conversion of healthy protein (from the end of a prion filament), and
• γ (m − 1) the fragmentation rate of a prion aggregate of size m.
2.2 Enzyme-mediated fragmentation
We now draw attention to an underlying assumption in these equations that we will
modify: for the mammalian prion PrP, it was assumed that the fragmentation rate
is an intrinsic function of the aggregate size itself. However, with yeast prion sys-
tems, it has been demonstrated that fragmentation requires the additional presence of
heat-shock protein 104 (Hsp104) (Satpute-Krishnan et al. 2007). Its under- or over-
expression can eliminate prion aggregates entirely (Chernoff et al. 1995). Additionally,
over-expressingSup35 results in a translational shift in the aggregate-size density (Der-
dowski et al. 2010)—the model equations of Masel et al. (1999) do not admit such
behavior (see Sect. 4.3), suggesting the possibility of a rate-limited fragmentation
mechanism rooted in the Hsp104 interactions.
Though yeast prion systems have been studied with the NPM (Tanaka et al. 2006),
webelieve the impact ofHsp104 tobenonnegligible and explicitly consider theHsp104
concentration and dynamics. We assume a prion aggregate of size i has i − 1 sites to
which a hexamer (the active unit) of Hsp104 can bind and subsequently fragment—
we denote such an aggregate with j bound hexamers as Xi, j . We note that there are
actually
(i−1
j
)
unique configurations of bound Hsp104 that Xi, j could refer to, but the
proposed kinetic equations will best be described by the amount of Hsp104 bound, not
their configuration. We use standard terminology for the enzyme kinetics (parameters
kon and koff), and for simplicity, we do not model the formation of Hsp104 hexamers
from monomers explicitly. We additionally define αh and μh for Hsp104 similarly
as αs and μs for Sup35. Lastly, while we write the dilution rates μs , μh , and μ0
separately, we will take them as all equal to the rate of growth of the yeast cell in
our numerical experimentation. We now propose our generalization in the form of the
following kinetic relations (and illustrate in Fig. 2).
Translation and Dilution
∅ μs↼−−⇁
αs
Sup35, ∅ μh↼−−⇁
αh
Hsp104, ∅ ←−
μ0
Xi, j ,
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(b)
(a)
Fig. 2 NPM is based on a random breaking of the prion aggregate (stars), while our model introduces
the Hsp104 enzyme (hexagons) that mechanistically fragments the aggregate. Healthy Sup35 (squares)
are converted by the ends of the prion aggregate in both models; proteins undergoing conversion are
represented with pentagons to demonstrate the active change in conformation. a Nucleated polymerization
model (stochastic fragmentation) b enzyme-limited polymerization model (mechanistic fragmentation via
Hsp104 chaperone)
Aggregation (Polymerization/Coagulation)
Sup35 + Xi, j −→
2β
Xi+1, j ,
Enzyme Kinetics
Hsp104 + Xi, j
koff( j+1)
↼−−−−−−−−−−−−−−⇁
kon(i− j−1)
Xi, j+1,
Fragmentation (with unspecified probability κ(m, n; i, j))
Xi, j −→
γ j
⎧
⎪⎪⎪⎨
⎪⎪⎪⎩
Xm,n + Hsp104 + Xi−m, j−n−1 m, i − m ≥ n0
mSup35 + (n + 1)Hsp104 + Xi−m, j−n−1 m < n0, i − m ≥ n0
Xm,n + ( j − n)Hsp104 + (i − m)Sup35 m ≥ n0, i − m < n0
iSup35 + jHsp104 m, i − m < n0.
The key unknown in our model is the density of configurations of bound Hsp104,
which is incorporated into the fragmentation kernel κ(m, n; i, j). Typically, all frag-
mentation sites in an aggregate are taken to be equally likely (Masel et al. 1999; Prüss
et al. 2006; Greer et al. 2006):
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m−(i− j)∑
n=0
κ(m, n; i, j) = 1
i − 1 . (5)
Furthermore, we require total Sup35 and Hsp104 to be conserved across fragmen-
tation events, which corresponds to
i−1∑
m=1
m−1∑
n=0
mκ(m, n; i, j) = i
2
and
i−1∑
m=1
m−1∑
n=0
nκ(m, n; i, j) = ( j − 1)/2. (6)
We claim that
κ(m, n; i, j) = 1
i − 1
(m−1
n
)(i−m−1
j−n−1
)
(i−2
j−1
) = 1
j
(m−1
n
)(i−m−1
j−n−1
)
(i−1
j
) (7)
is the natural choice, which follows from taking each
(i−1
j
)
configuration of Xi j to be
equally likely, which in turn corresponds to enzyme binding acting on a faster time-
scale than conversion and fragmentation (refer to the Supplemental Materials for the
argument).
2.3 Enzyme-limited nucleated polymerization model
With the biochemical processes defined, we are now able to formally derive our
ELNPM. We define s(t) as the concentration of soluble Sup35, η(t) as the concen-
tration of aggregates, z(t) as the concentration of bound Sup35 (z(t) ≥ n0η(t)),
h(t) as the concentration of unbound Hsp104, and zb(t) as the concentration of bound
Hsp104. Using [S] to denote the concentration of chemical species S, these definitions
correspond to s(t) = [Sup35](t), h(t) = [Hsp104](t), and
η(t) =
∞∑
i=n0
i−1∑
j=0
ui j (t), z(t) =
∞∑
i=n0
i−1∑
j=0
iui j (t), zb(t) =
∞∑
i=n0
i−1∑
j=0
jui j (t), (8)
where we have let ui j (t) = [Xi j ](t). Let us define a new quantity p(t) by the relation
zb(t) = p(t)[z(t) − η(t)] and apply the Law of Mass Action to our proposed kinetic
equations. We obtain
s′(t) = αs − μss(t) − 2βs(t)η(t) + γ (n0 − 1)n0η(t)
∞∑
i=n0
i−1∑
j=0
j
i − 1
ui j (t)
η(t)
(9a)
h′(t) = αh − μhh(t) + [(koff + γ )p(t) − konh(t)(1 − p(t))](z(t) − η(t))
+ γ (n0 − 1)(n0 − 2)η(t)
∞∑
i=n0
i−1∑
j=0
j ( j − 1)
(i − 1)(i − 2)
ui j (t)
η(t)
(9b)
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η′(t) = −(μ0 + γ p(t))η(t) + γ p(t)z(t) − 2γ (n0 − 1)η(t)
∞∑
i=n0
i−1∑
j=0
j
i − 1
ui j (t)
η(t)
(9c)
z′(t) = 2βs(t)η(t) − μ0z(t) − γ n0(n0 − 1)η(t)
∞∑
i=n0
i−1∑
j=0
j
i − 1
ui j (t)
η(t)
(9d)
p′(t) = konh(t)(1 − p(t)) − (koff + γ )p(t) + p(t)2 − 2βs(t)η(t)p(t)
z(t) − η(t)
+ γ (n0 − 1)(n0 − 2)η(t)
z(t) − η(t)
⎛
⎝
∞∑
i=n0
i−1∑
j=0
j
i − 1
ui j (t)
η(t)
− 1
p(t)
∞∑
i=n0
i−1∑
j=0
j ( j − 1)
(i − 1)(i − 2)
ui j (t)
η(t)
⎞
⎠ . (9e)
We note that ui j/η defines a probability mass function for the joint random variable
(I, J ) over {(i, j) : 0 ≤ j < i, i ≥ n0}, thus the sums may be interpreted as an
expected value. In the interest of obtaining a simple set of equations, we approximate
E
[
J
I − 1
]
≈ E[J ]/E[I − 1] = zb/(z − η) = p (10)
and
E
[
J (J − 1)
(I − 1)(I − 2)
]
≈ E[J ]2/E[I − 1]2 = p2. (11)
The error of this approximation is on the order of the inverse square of the aver-
age aggregate size, a size which is typically large by assumption (Prüss et al. 2006;
Greer et al. 2006; Doumic et al. 2009). (This analysis is provided in the Supplemental
Materials.)
Making these substitutions, we obtain the enzyme-limited, nucleated polymeriza-
tion model (ELNPM):
s′(t) = αs − μss(t) − 2βs(t)η(t) + γ p(t)(n0 − 1)n0η(t) (12a)
h′(t) = αh − μhh(t) + [(koff + γ )p(t) − konh(t)(1 − p(t))](z(t) − η(t)) (12b)
η′(t) = −[μ0 + γ p(t)(2n0 − 1)]η(t) + γ p(t)z(t) (12c)
z′(t) = 2βs(t)η(t) − μ0z(t) − γ p(t)n0(n0 − 1)η(t) (12d)
p′(t) = konh(t)(1 − p(t)) − (koff + γ )p(t) − p(t)
(
2βs(t)η(t)
z(t) − η(t) − γ p(t)
)
,
(12e)
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and marginal density equations
dum
dt
= −2βs(t)[um(t) − um−1(t)] − [μ + γ p(t)(m − 1)]um + 2γ p(t)
∞∑
i=m+1
ui (t).
(13)
We note that these equations may alternatively be derived by prescribing the bino-
mial form ui j (t) =
(i−1
j
)
p(t) j [1− p(t)]i− j−1ui (t), then finding the unique p(t) that
preserves Hsp104 conservation across fragmentation events.
We further observe that the systems (s, {um}) and (s, η, z) are identical to that of the
original NPM (Masel et al. 1999), except the constant fragmentation rate γ has been
replaced by the time-varying quantity γ p(t). This provides the interpretation of p(t) as
the measure of how effectively the system is fragmenting at a given time. Furthermore,
this formulation suggests a quasi-steady-state interpretation of our approximation,
since now every aggregate is always bound with Hsp104 proportionally as p(t); that
is, the enzyme binding reaches equilibrium before any conversion or fragmentation
events occur. We finally note that the first 2 terms in Eq. (12e) reflect a Michaelis–
Menten simplification of the enzyme kinetics (Segel and Slemrod 1989); however,
since Hsp104 off-binding results in a change in the amount of binding substrate with
probability γ /(γ + koff), we may view the last term as the correction to preserve
Hsp104 conservation.
Before detailed analysis of the ELNPM, we briefly examine the qualitative form
of the aggregate size distribution. In Fig. 3 we plot a typical equilibrium solution to
Eq. (13), where we have defined xm = un0−1+m/η to be the corresponding probability
mass function over the natural numbers. As expected, given the asymptotic similarity
Fig. 3 Plot of steady-state xm = um+n0−1/η with parameter values chosen from Tanaka et al. (2006),
appropriately modified to match the steady-state, effective fragmentation rate with the paper’s constant rate
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of our system to (Masel et al. 1999) (in that γ p(t) presumably converges to a fixed
γ˜ ), the equilibrium size density is of the same distribution.
3 Analysis of the ELNPM
We first prove a few results on existence and uniqueness for this system and then
provide a non-dimensionalized, transformed system we will use to study stability. We
analytically demonstrate the stability of the disease-free state and derive conditions
which will ensure aggregate persistence.
3.1 Existence and uniqueness of solutions
Theorem 1 Trajectories of Eq. (12) remain invariant under a bounded, “feasible”
subset of the non-negative cone R5+.
Proof Let us define the feasible subset to be the set of all (s, h, η, z, p) where
s, h, η, z ≥ 0 and 0 ≤ p ≤ 1, with the further restriction that z ≥ n0η,
0 ≤ s + z ≤ αs/μ0, and 0 ≤ h + p(z − η) ≤ αh/μ0. For analytical convenience, and
in line with typical parameter regimes, we assume μ0 ≤ μs, μh and γ2β < αsμs .
Now consider the violation of any single constraint. It is straight-forward to show
s′
∣∣
s<0, h
′∣∣
h<0, η
′∣∣
η<0, p
′∣∣
p<0 ≥ 0. Similarly, p′
∣∣
p>1 ≤ 0. Next, (z − n0η)′
∣∣
z<n0η
=
2βsη − μ0(z − n0η) − n0γ p(z − n0η) ≥ 0, which also demonstrates the non-
negativity of z since z ≥ n0η ≥ 0. Writing μs/μ0 = 1 + 
/μ0, we have
(s + z)′∣∣s+z>αs/μ0 = αs − μ0(s + z) − 
s ≤ 0. With a similar approach, we also find
(h + p(z − η))′∣∣h+p(z−η)>αh/μ0 ≤ 0. 
unionsq
Theorem 2 Solutions satisfy the existence and uniqueness criteria within the invari-
ant, feasible region.
Proof With the exception of the ηz−η term in p
′, the derivatives are polynomial in
the dependent variables, which yields continuous partial derivatives. Considering now
this last term, z ≥ n0η in our feasible region so we have 0 ≤ ηz−η ≤ 1n0−1 ≤ 1. This
term’s partial derivatives are also continuous in this region; let q(η, z) = η/(z − η).
Then, z/η = 1 + 1/q and
qη = η
′
z − η +
η(z − η)′
(z − η)2 =
η′
η
q + z
′ − η′
η
q2
= q(q − 1) (μ0 + γ p(2n0 − 1) − γ p(1/q + 1))
+ q2 (2βs − μ0(1 + 1/q) − γ pn0(n0 − 1))
= (q − 1) (qμ0 + qγ p(2n0 − 1) − γ p(q + 1))
+ q (2qβs − μ0(1 + q) − qγ pn0(n0 − 1)) ,
(14)
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and
qz = − η
(z − η)2 z
′ = −q2 z
′
η
= −q2 (2βs − μ0(1 + 1/q) − γ pn0(n0 − 1))
= −q (2qβs − μ0(1 + q) − qγ pn0(n0 − 1)) .
(15)
Thus, q, qη, qz are continuous in our region, even as η → 0+. This establishes exis-
tence and uniqueness. 
unionsq
3.2 Non-dimensionalized equations
We now reduce the ELNPM equations to non-dimensional form,
s′ = As(1 − s) − Bsη + (n0 − 1)n0 pη (16a)
h′ = Ah(1 − h) + r [(ω + n0 − 1) (k−1 p − k1h[1 − p]) + (n0 − 1)(n0 − 2)p2]η
(16b)
η′ = (ω − A0/p − n0 + 1) pη (16c)
ω′ = Bs − p(ω + 1)ω (16d)
p′ = k1h(1 − p) − k−1 p − p
(
Bs
ω + n0 − 1 − p
)
(16e)
where we have replaced z(t) by the displacement of the average aggregate size from
the minimum size ω(t) = z(t)/η(t) − n0 ≥ 0. We have scaled time by γ , s(t) and
η(t) by αs/μs and h(t) by αh/μh , and used the following non-dimensional constants
As = μs/γ, Ah = μh/γ, A0 = μ0/γ, B = 2αsβ
γμs
,
k−1 = (koff + γ )/γ, k1 = konαh
γμh
, r = αs/μs
αh/μh
. (17)
All subsequent analysis will done with respect to these non-dimensional equations.
We note that by construction k−1 > 1 and by assumption, B > 1.
3.3 Asymptotic behavior of ELNPM
With the nondimensional equations established, we next consider the asymptotic
behavior of the ELNPM. We call any trajectory satisfying limt→∞ η(t) = 0 disease-
free; otherwise, we call the prion state persistent. Prüss et al. (2006) observed that
an appropriate transformation could reduce the NPM equations to the standard SEIS
model of mathematical epidemiology—a model which is governed entirely by a sin-
gle parameter R0 (the basic reproductive number). If R0 < 1, the only equilibrium is
disease-free and is globally stable. If R0 > 1, a unique endemic equilibrium appears
and exchanges stability with the disease-free state; that is, the endemic equilibrium
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is asymptotically globally stable (Li et al. 1999). Applying the transformation from
Prüss et al. (2006), our R0 will vary in time through its dependence on p(t):
R0(p) = B/p
(A0/p + n0 − 1)(A0/p + n0) . (18)
It is convenient to think of the quantity R0(p(t)) = Rt as the effective reproduc-
tive number of the disease system, where typically Rt < R0. Though p(t) appears
to always converge to a fixed steady-state value, it does so in a non-trivial way mak-
ing it difficult to provide a Lyapunov analysis. Instead, we provide a local analysis
of the disease-free state and offer numerical evidence in support of R0(pdisease-free)
determining global stability.
3.3.1 Disease-free steady state
At a disease-free equilibrium, we have η = 0 and subsequently, s = h = 1. Thus, we
need only study solutions to
0 = B − pω(ω + 1)
0 = k1(1 − p) − k−1 p + p2 − Bp
ω + n0 − 1 .
(19)
This system has five solutions in general, though we shall show there is only a single
solution inside our feasible region.
Theorem 3 There is a unique solution to Eq. (19) in our feasible region of trajectories.
Proof We may write p = p(ω) = B/[ω(ω + 1)]; then ω satisfies
0 = f (ω) = B2(n0 − 1) − B(n0 − 1)(k1 + k−1)ω
− [B2 + Bk−1n0 + {1 + (B − 1)n0}k1]ω2
[−B(k1 + k−1) + k1(2n0 − 1)]ω3 + k1(n0 + 1)ω4 + k1ω5.
(20)
Since k1k1+k−1 < 1 < B,weobserve2 sign changes in the coefficients of f (ω), implying
0 or 2 real roots by Budan’s theorem (Akritas 1982). We may also write ω = ω(p) =
−1/2 + √1/4 + B/p. Since p < 1, we have ω > ωmin = −1/2 + √1/4 + B.
However, f (0) = B2(n0 − 1) > 0, f (ωmin) = − B22 (2B + (k−1 − 1)(2n0 − 3 +√
1 + 4B)) < 0, and limω→∞ f (ω) > 0. Thus, by sign analysis we have an infeasible
root ω ∈ (0, ωmin) and a feasible root ω > ωmin. 
unionsq
We now establish local stability criteria of this root; let p0 and ω0 be the unique
solution to Eq. (19).
Theorem 4 The unique disease-free equilibrium is locally stable when R0(p0) < 1
and unstable when R0(p0) > 1.
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Proof The eigenvalues of the localized Jacobian will satisfy
0 = (As + λ)(Ah + λ)(p0(ω0 + n0 − 1) − A0 − λ)
×
⎡
⎣λ
2 +
(
2ω0 p0 + k1 + k−1 − p0 + Bω0+n0−1
)
λ
+p0(1 + 2ω0)
(
k−1 + k1 − 2p0 + Bω0+n0−1
)
+ Bp0ω0(ω0+1)
(ω0+n0−1)2 .
⎤
⎦
(21)
Of the five roots, the first 2 are clearly negative. The quadratic factor will also admit 2
stable roots:we see that its quadratic and linear coefficients are strictly positive andnow
show that the constant term is as well. If k1 > 0, then k1+k−1−2p0 > 2(1− p0) > 0.
If not, then consider p′ at p = k1:
p′ < k1(1 − k1) − k−1k1 + k21 = k1(1 − k−1) < 0. (22)
So, p(t) < k1 for all time, implying p0 < k1 and k1 + k−1 − 2p0 > k−1 − p0 >
1 − p0 > 0.
Finally, the remaining root will be negative when p0(ω0 − n0 + 1) − A < 0.
Substituting ω0 = −1/2+ √1/4 + B/p0 and simplifying, our expression reduces to
R0(p0) = B/p0
(A0/p0 + n0)(A0/p0 + n0 − 1) < 1. (23)

unionsq
We support this claim numerically in Fig. 4, where we vary R0(p0) across a range
of parameters (described in Table 1).We observe that when R0(p0) > 1, there appears
to be an attractive endemic equilibrium.
Fig. 4 Non-dimensionalized plots of aggregate density over time with varying R0 = R0(p0). The system
is initialized with a 10−9 perturbation of aggregated protein from an otherwise healthy initial state
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Table 1 A table of values used for the plots
Figures αh (µMmin
−1) β (µM−1min−1) γ (min−1) kon (µM−1min−1) koff (min−1)
3, 6 and 8 0.002567 6.0 0.00294 0.20000 2.00000
4 and 5 0.00142 – 0.00294 0.15964 2.93706
7 4.16503 × 10−6 0.216456 0.0421667 81.8524 4.38533
8 – 0.216456 0.0421667 81.8524 4.38533
9a 0.002567 (6.0, 6.0) (0.00294,0.00294) (0.2, –) (2.0, –)
9b 0.002567 (6.0, 8.0) (0.00294,0.002) (0.2, –) (2.0, –)
10 0.002567 (6.0, 8.0) (0.00294,0.002) (0.2, 0.21567) (2.0, 2.0)
In all cases, αs = 0.0154µMmin−1, n0 = n1 = n2 = · · · = 5, and μs = μh = μ0 = μ1 = μ2 = · · · =
0.0077min−1
3.3.2 Endemic steady state
The local instability of the disease-free equilibrium yields a persistent disease state;
however, the numerical experimentation inFig. 4 suggests further that there is an attrac-
tive, endemic equilibrium. Generally speaking, steady-state solutions to our system
will be solutions of a quintic polynomial in five variables, thus preventing closed-form
descriptions of such states. However, one can parameterize these values in terms of a
fixed (but unknown) value p˜ corresponding to p = p˜:
s˜ = (A0/ p˜ + n0 − 1)(A0/ p˜ + n0)
B/ p˜
(24a)
h˜ = 1 − r(As/Ah)(1 − s˜) p˜
(
1 − 1
A0/ p˜ + 2n0 − 1
)
(24b)
η˜ = (As/A0) 1 − s˜
A0/ p˜ + 2n0 − 1 (24c)
ω˜ = A0/ p˜ + n0 − 1, (24d)
where p˜ satisfies
0 = k1h˜(1 − p˜) − k−1 p˜ + p˜2 − Bs˜ p˜
ω˜ + n0 − 1 . (25)
We note that this quadratic is uniquely invertible within our feasible region, which
yields the recursive relation
2 p˜ =
(
k−1 + k1h˜ + Bs˜
ω˜ + n0 − 1
)
−
√(
k−1 + k1h˜ + Bs˜
ω˜ + n0 − 1
)2
− 4k1h˜.
(26)
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Incidentally, if we suppose k1h + k−1  Bs˜ω˜+n0−1 , k1h, then we obtain
p˜ = k1h
k1h + k−1 + O
(
1
(k1h + k−1)2
)
. (27)
We draw attention to the similarity between Eq. (27) andwhat would be theMichaelis–
Menten value for p˜.
Our feasible region requires s, h, η, ω > 0; s˜ and ω˜ are always positive, while
η˜ > 0 ⇒ s˜ < 1 ⇒ R0( p˜) > 1. This also gives us h˜ > 0, since we typically
assume αh ≤ αs ⇒ r(As/Ah) ≤ 1, which implies
h˜ > 1 − (1 − s˜) p˜
(
1 − 1
A0/ p˜ + 2n0 − 1
)
> 0. (28)
Thus, we will have endemic equilibria when Eq. (26) has solutions satisfying
R0( p˜) > 1. Based on considerable numerical studies, we conjecture that this solution
uniquely exists and is globally asymptotically stable when R0(p0) > 1.
4 Discussion
Formulating the ELNPM allows us to consider aspects of prion aggregate dynamics
that cannot be explained by prior mathematical approaches that neglected the role
of the Hsp104 chaperone in fragmentation. We first demonstrate that the NPM is a
limiting case of the ELNPM and comment on implications of the ELNPM to the larger
question of the appearance of prion strains in a population. We then demonstrate that
the ELNPM is the first model capable of supporting two experimentally observed
phenomena. First, the ELNPM is the first model capable of reproducing shifts in
the aggregate densities associated with increases in synthesis of Sup35. Finally, we
demonstrate that the binding kinetics of Hsp104 in the ELNPM allows the possibility
of multiple co-existing prion strains. Intriguingly, the co-existence of multiple strains
is thought to be crucial towards understanding the transmission of prion diseases
between species (Chien et al. 2004).
4.1 The NPM is a limiting case of ELNPM
Our moment-closed ELNPM model, Eq. (9), is nearly identical to the original NPM
model but with a time-varying, effective fragmentation rate γ p(t) instead of the con-
stant γ . When p(t) → p˜, the dynamics of ELNPM will mirror that of the NPM with
γ replaced by γ p˜. As such, it is convenient to think of the NPM as a quasi-steady-state
approximation of the full enzyme kinetics we have considered in our model. We infor-
mally used this observation in Sect. 3.3 to motivate (but not prove) global stability
based on known results of the NPM system.
We plot in Fig. 5 p(t) over the same parameters in Fig. 4 and note that—since yeast
has a doubling time of roughly 90min (Hartwell and Unger 1977) – p(t)will not reach
its asymptotic value for a few cell-divisions. As such, even though the NPM represents
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Fig. 5 p(t) over time with varying R0 = R0(p0); parameters are the same as in Fig. 4. The transient
fragmentation efficiency may be higher (for small R0) or lower (for large R0) than the asymptotic efficiency
a quasi-steady-state approximation it may not represent the aggregate dynamics during
the early cell divisions following the introduction of prion aggregates.
4.2 Transient fragmentation efficiency may impact prion stability
Although the NPM may be viewed as an asymptotic simplification of the ELNPM,
we remark that the differences in transient behavior may provide insight into the
underlying stochastic dynamics that arise when a single prion seed is introduced into
a healthy yeast colony. The ELNPM predicts an initial fragmentation rate that can be
larger or smaller than the asymptotic rate—this is because the availability of enzyme
(Hsp104) is much larger than the availability of substrate (binding sites) in this initial
configuration (see Fig. 5).
Since aggregate amplification is essential to spreading a prion disease these tran-
sient fragmentation rates may impact prion stability. For example, a higher transient
fragmentation rate for a prion strainwith low R0 would represent a barrier to successful
“seeding” of the prion state than would otherwise be predicted by a constant fragmen-
tation rate. This provides a plausible mechanism for the removal of an initial prion
aggregate appearing in a population and therefore the low frequency of spontaneous
appearance of the prion state.
4.3 Hsp104 acts as a rate limiter for fragmentation
We noted in Sect. 2 that the NPM does not admit translational shifts in the aggregate
density as a function of increasing synthesis of the prion protein (αs), we now for-
mally demonstrate this is the case. Let us revisit the quantity um(t), the density of
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Fig. 6 Theoretical shifts in the steady-state concentration of aggregate size distributions {mum } by increas-
ing the synthesis of normal protein (αs ). Left mum = ηmxm−n0+1 from the NPM. Though xm is invariant
to αs , η does have a dependency, resulting in the small changes in scaling. Right mum from our ELNPM.
Both the scaling and translation are affected by αs . Initial kinetic parameters are as in Fig. 3
aggregates of size m. We write xm = um+n0−1/η—this quantity defines a probability
mass function that is independent of the amount of aggregated protein. In our rescaled
variables, we have
x ′m = −Bs(xm − xm−1) − p(m + ω + 1)xm + 2p − 2p
m−1∑
i=0
xi . (29)
Davis and Sindi (2015) gave a closed-form for xm at steady-state:
xm = m(2ζ + m − 1) Γ (ζ
2)
Γ (ζ 2 + m + 1)ζ
m(ζ − 1)m−1, (30)
where ζ = μ
γ p˜ + n0.
The size distribution’s dependence on αs can only occur through its relationship
with the steady-state fragmentation efficiency p˜. This is fixed in the NPM, thus the
size distribution will not change in response to changes in αs . This is in contradiction
to the experimental results described byDerdowski et al. (2010). Since our model does
allow p˜ to vary as a function of the kinetic parameters, we are able to numerically
investigate qualitative shifts in the distribution. We demonstrate these shifts in Fig. 6,
which are in qualitative agreement with the experiments of Derdowski et al. (2010). As
such, experimental evidence supports that fragmentation can not be purely a function
of the number of available fragmentation sites and must depend on the amount of
Hsp104 in the system.
4.4 Prion extinction and Hsp104 expression levels
Beyond translational shifts in aggregate size distribution, the [PSI+] prion phenotype
in yeast has been shown to be very sensitive to the amount of Hsp104 in the system
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Fig. 7 Hsp104 production is up-regulated or Hsp104 is deactivated after 3 h, both by a factor of 104. The
new system in either case is unable to stably support the presence of prion aggregates with our engineered
parameters
(Higurashi et al. 2008; Doyle and Wickner 2009; Shorter and Lindquist 2008). Our
mathematical formulation correctly captures the dependency of all prions to the under-
expression of Hsp104. In contrast, and in agreement with recent experimental studies
(Klaips et al. 2014), over-expression of Hsp104 does not necessarily drive prions to
extinction.
First, sufficiently high concentrations of guanidine hydrochloride GdnHCl have
been shown to severely disrupt the fragmentation process by inactivating Hsp104
(Ferreira et al. 2001; Byrne et al. 2007). Since fragmentation is halted the total number
of aggregates will not change and aggregates will eventually be lost through dilution
in the population due to cell division. Over time the population will be cured of the
prion disease as the fraction of cells with aggregates approaches zero.
Quantitatively, we treat the inactivation of Hsp104 as letting kon → 0. In the limit,
we’ll obtain p′ = −k1 p + p2 − Bspω+n0−1 < −
Bsp
ω+n0−1 ≤ 0 ⇒ p → 0+. With
p = 0, we have η′ = −A0η ≤ 0 ⇒ η → 0+, which corresponds to the elimination
of prion aggregates. We demonstrate this in Fig. 7.
While earlier studies seemed to indicate over-expression ofHsp104 could cause loss
of the prion state (Chernoff et al. 1995), more recent experimental evidence indicates
that Hsp104 over-expression is not sufficient to drive prions to extinction (Klaips et al.
2014). In our formulation over-expressing Hsp104 drives p → 1. This is readily
demonstrated by assuming k1h = 1/
  1 and rescaling time by this quantity; then
p′ = 1 − p + O(
). However, as is experimentally, this alone is not mathematically
sufficient to cure the prion state.
Consider an endemic state with R0( p˜) = B/ p˜(A0/ p˜+n0)(A0/ p˜+n0−1) > 1. Depending on
the other kinetic parameters, R0 may be either increasing or decreasing with respect
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Fig. 8 The reproductive number R0 as a function of αh . Prion strains will only be driven to extinction by
Hsp104 over-expression if limαh→∞ R0(αh) < 1
to p˜—prion extinction would only occur if R0(1) < 1. Specifically, sgn(R′0(p)) =
sgn(A20 − (n0 − 1)n0 p2). If A0 > n0 − 1, R0 is always increasing and extinction
is impossible under our model. This is consistent with the belief that there are other
(unmodeled) factors more likely to contribute to prion phenotype loss (Palmer et al.
2011; Klaips et al. 2014); nonetheless, we do provide an engineered parameter set
(described in Table 1) that demonstrates prion extinction bymaximizing fragmentation
efficiency in Fig. 7. We additionally plot the dependence of R0 on αh in this parameter
set as well as the original set we’ve used in Fig. 8.
4.5 Stability of the coendemic prion strains
Up until this point we have considered the aggregates of a single prion species; how-
ever, a prion protein is capable of adopting a host of misfolded confirmations each of
which is capable of the biochemical processes of conversion of normal protein and
fragmentation (Sindi and Serio 2009; Tuite and Cox 2003; Tuite and Serio 2010).
That is, [PSI+] or PrPSc does not refer to a single prion phenotype, but many related
ones, each characterized by different pathology (implying different kinetic parameter
values). These distinct prion states are referred to as prion “strains.”
Biologists haveobservedmultiple coexisting strains (Strbuncelj 2009; Polymenidou
et al. 2005), but there has been limitedmathematicalmodeling ofmultiple prion strains.
Previously, Tanaka et al. (2006) considered the NPM, under the continuous relaxation
of aggregate sizes, with n0 = 1 and demonstrated that if two strains were present
then, asymptotically, one strain would dominate and drive the other to extinction. The
outcomewas determined by the strainwhich hadmaximizedβγ (which is proportional
to the reproductive number in the case of continuous-size, n0 = 1 NPM). Since
level curves of βγ represent a set of measure 0 in parameter space, realistically this
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prevents asymptotic prion strain coexistence. By coexistence, we mean that there
exists i = j such that limt→∞ ηi (t), η j (t) > 0 when ηi (0), η j (0) > 0 (where ηi is
the concentration of aggregates of strain i).
We now generalize the ELNPM to include multiple prion strains, each capable
of converting the same normal protein. Because aggregation is based on conversion
to a particular prion strain conformation, we consider an aggregate as consisting of
misfolded protein of a single strain. We write the equations for k strains with similar
constants as before, but scale time by Γ = ∑ki=1 γi and write Γi = γi/Γ :
s′ = As(1 − s) − s
k∑
i=1
Biηi +
k∑
i=1
Γi (ni − 1)ni piηi (31a)
h′ = Ah(1 − h) + r
k∑
i=1
[(ωi + ni − 1)
(
ki,−1 pi − ki,1h[1 − pi ]
)
+ (ni − 1)(ni − 2)Γi p2i ]ηi (31b)
η′i = [Γi piωi − Ai − (ni − 1)Γi pi ] ηi (31c)
ω′i = Bi s − Γi pi (ωi + 1)ωi (31d)
p′i = ki,1h[1 − pi ] − ki,−1 pi − pi
(
Bi s
ωi + ni − 1 − Γi pi
)
. (31e)
Because our mathematical formulation also requires the molecular chaperone
Hsp104, this opens up the possibility for an alternative pathway to prion strain
coexistence—rather than out-compete solely on conversion β and fragmentation γ ,
a second strain may be more efficient at sequestering Hsp104 (kon/koff). Increasing
this ratio improves the strain’s own fragmentation efficiency, as well as decreases the
other strain’s efficiency by decreasing the amount of available Hsp104.
It is helpful to think of prion strain competition and coexistence in terms of the
reproductive numbers described in Sect. 3.3. Intuitively, the strain with the highest
reproductive number will dominate and drive others to extinction. As already stated,
this is exactly what Tanaka et al. (2006) observed—however, recall that with the NPM,
the reproductive number is fixed, so there will not be any dependency on the kind of or
number of strains present. Our model, however, has an effective reproductive number
dependent on the current fragmentation efficiency. In terms of strain-specific constants,
this number is given by
Ri (pi ) = Bi/pi
(Ai/pi + ni − 1)(Ai/pi + ni ) . (32)
The fragmentation efficiency of strain i , pi , is dependent on the current concentration
of soluble Sup35 and free Hsp104 (Eq. (31e)), which in turn depend on all of the
strains’ concentrations. As such, the reproductive numbers of the strains are coupled
to one another. These nonlinear, secondary interactions make analytic determinations
of coexistence difficult. However, we are able to numerically demonstrate coexistence
of prion strains (Fig. 9).
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Fig. 9 Different parameter regimes exhibit fundamentally different behavior with respect to coendemic
stability. The labeled regions denote the surviving strain, and gray regions denote areas of mutual coexis-
tence. Refer to Table 1 for the parameter values. a No stable coexistence, b region of stable coexistence
Fig. 10 Plots of a specific parameter set admitting asymptotically stable, coendemic behavior. We note that
the size densities and aggregated protein take on distinct values, despite very similar reproductive numbers.
a Steady-state aggregate densities, b concentration of Sup35 in aggregates
Remarkably, Fig. 9b demonstrates that strain coexistence is possible for parameters
lying in a non-zero area of parameter space. We note that, in contrast to prior models,
this type of coexistence is biologically feasible because is it robust to small pertur-
bations in parameter space. Thus, our numerical studies demonstrate that strains with
different reproductive numbers (in isolation) can coexist. Further, at the coendemic
state each strain’s “cooperative” reproductive number is different from their isolated
value, but equal to each of the other strains’ cooperative numbers.
We choose two specific parameter sets from Fig. 9b and plot of their steady-state,
cooperative size densities in Fig. 10a and concentration of aggregated Sup35 in each
strain over time in Fig. 10b.
5 Conclusion
In this work we successfully developed a mathematical formulation of aggregate
dynamics where fragmentation occurs through the molecular chaperone Hsp104.
We demonstrate that, under certain restrictions, our model reduces to a numerically
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tractable formwhich we call the ELNPM. By including chaperone-mediated fragmen-
tation, this work represents an important step towards a more complete understanding
of prion and protein misfolding in vivo.
We derived a unique disease-free steady-state of the ELNPM and analyzed its
stability. We demonstrated that the ELNPM supports experimentally observed results
such as shifts in the aggregate-size distribution with increasing Sup35 synthesis and
response to over- and under- expression of Hsp104. Additionally, it represents a first
step towards quantifying prion strain coexistence.
While the ELNPM successfully describes the effects of varying amounts of Sup35
and Hsp104 in the system, we note that there are factors common to enzyme-substrate
kinetics that were not included in our model. First, in many biochemical systems there
is evidence of cooperation between binding sites (Nelson et al. 2008). Since there is no
evidence of interaction between binding sites for Hsp104, we have modeled binding
events as purely a function of the free enzyme and available binding sites.
Second, by assuming that koff was large we were able to assume that for an aggre-
gate consisting of i Sup35 monomers with j sites bound by Hsp104, all possible
configurations of bound Hsp104 are equally likely (see the Supplemental Material).
Since under normal expression Hsp104 is observed to be only minimally bound to
[PSI+] aggregates (Klaips et al. 2014), we interpret this to indicate that koff must
indeed be large relative to kon. Third, we considered a generalization of the uniform
fragmentation kernel which corresponds to equality in fragmentation at all binding
sites. Together, these three assumptions allowed the use of analytical approaches pre-
viously employed in the analysis of the NPM to demonstrate existence, uniqueness
and asymptotic stability of the disease-free steady-state.
Beyond Hsp104, other enzymes have been identified as important players in the
dynamics of prion aggregate fragmentation (Inoue et al. 2004; Shorter and Lindquist
2008). As such, ourmathematical formulationmay be taken as the representing collec-
tive impact of enzymes on fragmentation. However, compared to the other enzymes,
Hsp104 occurs in the lowest molecular number (Ghaemmaghami et al. 2003) and is
thus likely to represent a rate limiting step. In addition, we have evaluated our model
by comparison to experimental results on the [PSI+] prion which has shown to have
greatest sensitivity to Hsp104 (Higurashi et al. 2008). Lastly, again note that the form
of Hsp104 is a hexamer (Doyle and Wickner 2009)—we have assumed the kinetics of
hexamer formation are not relevant to the aggregate dynamics.
In addition to including additional biological complexities, in future studies we
plan to investigate global asymptotic stability and explore the conditions underlying
prion strain coexistence.
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